Anti-Human MUC5AC Recombinant Antibody (Ensituximab) (CAT#: TAB-200)

Recombinant monoclonal antibody to 5AC. Ensituximab is a chimeric monoclonal antibody used in the treatment of cancers.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Tested Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
SDS-PAGE

Figure 1 Anti-Human MUC5AC Recombinant Antibody (TAB-200) in SDS-PAGE

Figure 1 Anti-Human MUC5AC Recombinant Antibody (TAB-200) in SDS-PAGE

Lane 1: Non-reduced mAb
Lane 2: Reduced mAb

SEC-HPLC

Figure 2 Anti-Human MUC5AC Recombinant Antibody (TAB-200) in SEC-HPLC

Figure 2 Anti-Human MUC5AC Recombinant Antibody (TAB-200) in SEC-HPLC

The purity of TAB-200 was greater than 95% as determined by SEC-HPLC.


Specifications

  • Immunogen
  • M1 mucin preparation from the fluid of an ovarian mucinous cyst.
  • Host Species
  • Mouse
  • Derivation
  • Chimeric (mouse/human)
  • Type
  • IgG1 - kappa
  • Specificity
  • Tested positive against native human antigen.
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in IP, IF, FuncS, FC, Neut, ELISA, ICC and most other immunological methods.
  • CAS
  • 1092658-06-4
  • Generic Name
  • Ensituximab
  • UNII
  • F988K568V2
  • MW
  • 142.8 kDa
  • Related Disease
  • Colorectal cancers

Product Property

  • Purity
  • >95.0% as determined by analysis by RP-HPLC.
  • Storage
  • At -20°C for one year.

Target

  • Alternative Names
  • Ensituximab;1092658-06-4;NPC-1C;NEO-101;MUC5AC;mucin 5AC, oligomeric mucus/gel-forming;mucin 5, subtypes A and C, tracheobronchial/gastric;mucin-5AC;MUC5;gastric mucin;tracheobronchial mucin;major airway glycoprotein;lewis B blood group antigen;mucin-5 su

Related Resources

  • Biosimilar Overview
Please refer to Ensituximab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Ensituximab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Ensituximab"

Afuco™ Anti-MUC5AC ADCC Recombinant Antibody (Ensituximab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to 5AC. Ensituximab is a chimeric monoclonal antibody used in the treatment of cancers.

See other products for "MUC5AC"

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-200 Afuco™ Anti-MUC5AC ADCC Recombinant Antibody (Ensituximab), ADCC Enhanced IP, IF, FuncS, FC, Neut, ELISA ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-200. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare